Skip to main content Skip to main navigation menu Skip to site footer
Experimental Oncology
  • Home
    • About this Journal
    • Privacy Statement
    • Open access policy
    • Cost of publication
    • Guides for authors
  • Current
  • Archives
  • Editorial Board
  • Submissions
  • Archive 2018-2006
  • Contact
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

Found 217 items.
  • Redox dependent features of tumors, adipose tissue, neutrophiles and platelets in patients with metastatic colorectal cancer

    A.P. Burlaka, S.V. Virko, A.A. Burlaka, K.L. Krupnyk
    261-265
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16571
  • HUMAN MICROBIOTA AND BREAST CANCER

    Yu.V. Shvets, O.O. Lykhova, V.F. Chekhun
    95-106
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17855
  • WELCOME ADDRESS

    V. Chekhun
    186
    04.06.2023
  • Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer

    S.I. Kirkilevsky, P.S. Krakhmalev, N.V. Malyshok, T.V. Zadvornyi, T.V. Borikun, T.M. Yalovenko
    167-171
    31.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.14822
  • EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA

    Wani Zahoor, Arshad A. Pandith, Syed Nisar, Iqbal Qasim, Menka Surana, Farooq A. Ganie, Usma Manzoor, Sajad H. Arif, Shayaq Ul Abeer Rasool, Adil Lateef, Parveen Shah, Rashid A. Bhat
    203-210
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.203
  • MATERIALS OF NOBEL SYMPOSIUM 175: PRECISION MEDICINE TRANSFORMS HEALTHCARE: A NEW TRAJECTORY FOR RESEARCH AND INNOVATION SEPTEMBER 20—22, 2023, STOCKHOLM, SWEDEN

    L. Kovalevska, E. Kashuba
    531-534
    12.12.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.531
  • PD-1 AND TIM-3 BLOCKING CANNOT ENHANCE APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY PERIPHERAL BLOOD CD8+ T CELLS

    S. Jafarkhani, H. Hossein-Nataj, M. Eslami-Jouybari, M. Ghoreishi, H. Asgarian-Omran
    287-294
    09.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18975
  • EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW

    R. SARATHI, S. SARUMATHY, V.M. DURAI MAVALAVAN
    185-191
    19.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.03.185
  • THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA

    О. Kravets, O. Burtyn, T. Borikun, O. Rossylna
    187-194
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.187
  • ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS

    E.A. Domina, O.L. Kopylenko
    186-189
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18530
  • Quinazoline compounds for antitumor treatment

    G.I. Solyanik
    3-6
    08.06.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12414
  • EXPRESSION OF GENES INVOLVED IN P53 PATHWAY REGULATION IN NEUROBLASTOMA: A SHORT REVIEW

    M. Inomistova, H. Klymniuk, N. Khranovska , S. Pavlyk, E. Shaida, O. Gorbach, O. Skachkova, D. Shymon
    266–271
    07.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18960
  • ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS

    O. Pridko, T. Borikun, O. Rossylna, A.V. Rusyn
    180-186
    11.10.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.180
  • Comparative evaluation of purine dysmetabolism in gastric and pulmonary adenocarcinomas

    Y.V. Dumanskiy, O.Y. Stoliarova, О.V. Syniachenko, R.F. Aliev, М.V. Iermolaeva, О.P. Sokrut
    220-223
    31.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.15068
  • IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY

    M. GOLOVENKO, I. VALIVODZ, A. REDER, V. LARIONOV
    51-59
    11.07.2025
    DOI: https://doi.org/10.15407/exp-oncology.2025.01.051
  • PROGNOSTIC VALUE OF THE DENSITY OF TUMOR-INFILTRATING LYMPHOCYTES AND ITS ASSOCIATION WITH CLINICAL-MORPHOLOGICAL FEATURES OF COLON ADENOCARCINOMAS

    B. SHKURUPII, L. ZAKHARTSEVA
    45-52
    31.05.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.01.045
  • IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY

    Yu.V. Dumanskyi, S.I. Kirkilevskyi, O.M. Sulaeva, V.O. Polyasnyi, A.O. Mashukov, L.A. Kovalevska, R.R. Yarema, M.A. Ogorchak
    324–326
    07.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18903
  • PHARMACOGENETIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY

    L. Fishchuk, Z. Rossokha, N. Levkovych, O. Sheiko, O. Ievseienkova, L. Brisevac, O. Popova, V. Vershyhora, N. Gorovenko
    408-420
    05.03.2026
    DOI: https://doi.org/10.15407/exp-oncology.2025.04.408
  • GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS

    L. Fishchuk, O. Skavinska, O. Ievseienkova, Z. Rossokha, L. Sheiko
    399-408
    12.12.2023
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.399
  • Peculiarities of epithelial-mesenchymal transition in endometrial carcinomas

    I. Nesina
    282-289
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16982
  • SEVERE DISEASE PROGRESSION OF POSTMOLAR GESTATIONAL NEOPLASM IN A VIETNAMESE YOUNG FEMALE PATIENT AFTER TREATMENT REFUSAL: INSIGHTS FROM A CASE REPORT AND LITERATURE REVIEW

    THANH NHAN VO, PHUC NHON NGUYEN
    154-164
    09.10.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.02.154
  • PRIMARY OVARIAN SYNOVIAL SARCOMA — A CASE REPORT

    A. Yordanov, K. Janeva, S. Mateva, Y. Kornovski, S. Kostov, S. Slavchev, Y. Ivanova, M. Nikolova
    334-336
    09.03.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19072
  • Collision breast cancer and chronic lymphocytic leukemia/small lymphocytic lymphoma in a single lymph node (clinical case)

    L. Zakhartseva, M. Yanovytska
    274-276
    26.05.2023
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16486
  • THE UBIQUITIN-PROTEASOME SYSTEM IN CANCER: MECHANISMS, TARGETS AND THERAPEUTIC POTENTIAL

    D. Nishchenko, S. Antonenko, D. Gurianov, M. Tesliuk, G. Telegeev
    395-407
    05.03.2026
    DOI: https://doi.org/10.15407/exp-oncology.2025.04.395
  • Digital Pathology as an Innovative Tool for Improving Cancer Diagnosis and Treatment

    T. ZADVORNYI
    289-294
    12.12.2024
    DOI: https://doi.org/10.15407/exp-oncology.2024.04.289
176 - 200 of 217 items << < 3 4 5 6 7 8 9 > >> 

Language

  • Українська
  • English

Make a Submission

Make a Submission

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

More information about the publishing system, Platform and Workflow by OJS/PKP.